KZIA
Kazia Therapeutics Ltd
9.30$
+0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.3% | 73.6% | 73.4% | 83.8% | 83.5% | 90.5% | 84.5% | 85.6% | 98.4% | 98.7% | 99.1% | 99.1% | 99.5% | 99.7% | 99.7% | 56.6% | 96.8% | 96.0% | 54.2% | 32.9% | 35.6% | 46.2% | 50.6% | 26.3% | 38.4% | 28.5% | 81.4% | |
| 52.8% | 44.3% | 50.9% | 64.5% | 61.1% | 75.5% | 70.0% | 47.7% | 76.9% | 64.5% | 88.1% | 78.4% | 47.3% | 92.9% | 92.9% | 53.7% | 96.2% | 94.2% | 40.3% | 21.1% | 25.7% | 38.0% | 47.5% | 20.5% | 18.7% | 7.7% | 71.7% | |
| 52.8% | 44.3% | 50.9% | 64.5% | 61.1% | 75.5% | 70.0% | 65.6% | 76.9% | 79.2% | 88.1% | 78.4% | 47.3% | 92.9% | 92.9% | 53.7% | 96.2% | 94.2% | 40.3% | 21.1% | 25.8% | 38.0% | 47.5% | 20.5% | 18.7% | 7.7% | 71.7% | |
| 8.8% | 10.4% | 8.4% | 7.3% | 8.7% | 3.8% | 5.2% | 7.9% | 8.3% | 11.4% | 4.8% | 8.3% | 43.0% | 0.9% | 4.5% | 1.3% | 0.0% | 0.3% | 0.0% | 0.0% | 7.4% | 0.0% | 0.1% | 0.1% | 0.4% | 0.6% | 1.5% | |
| 16.9% | 18.9% | 12.3% | 11.2% | 12.6% | 10.1% | 8.1% | 10.8% | 7.6% | 4.4% | 3.5% | 8.1% | 5.1% | – | 0.0% | 0.0% | 0.0% | 1.2% | 0.0% | 0.0% | -7.3% | 0.0% | -0.1% | – | -13.5% | – | – | |
| – | 11.6% | 4.8% | 8.4% | 11.0% | 6.1% | 6.6% | 6.5% | 1.4% | 1.3% | 0.8% | 0.8% | 0.6% | 0.3% | 0.1% | 0.2% | 0.1% | 1.7% | 1.4% | 0.0% | 0.0% | – | – | – | – | – | – | |
| – | 0.3% | 0.1% | 0.2% | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 0.5% | 0.4% | 0.4% | 0.4% | – | – | – | – | – | – | – | – | – | – | 28.2% | 42.1% | 3.0% | 2.3% | 44.3% | 51.7% | 63.7% | 53.8% | 37.9% | 53.3% | 61.5% | 71.3% | 17.9% | |
| 15.0% | 18.9% | 15.2% | 12.7% | 16.6% | 37.8% | 10.4% | 12.8% | 13.1% | 17.9% | 24.0% | 31.7% | 65.3% | 43.1% | 43.1% | 69.7% | 3.9% | 4.5% | 29.4% | 31.7% | 33.1% | 38.8% | 34.8% | 49.1% | 57.1% | 146.4% | 237.0% | |
| 12.3% | 15.3% | 11.1% | 8.7% | 13.0% | 9.3% | 10.0% | 12.1% | 12.6% | 17.0% | 23.3% | 30.9% | 64.5% | 43.0% | 43.0% | 69.7% | 3.9% | 4.0% | 15.0% | 13.8% | 10.4% | 22.0% | 14.3% | 18.7% | 26.9% | 119.5% | 231.9% | |
| 1.6% | 2.9% | 0.5% | 1.4% | 1.3% | 1.1% | 1.1% | 0.0% | – | – | – | – | 10.8% | – | 31.7% | 58.1% | 0.0% | 0.0% | 0.0% | 0.3% | 0.0% | – | – | 5.1% | 6.4% | 2.9% | 6.5% | |
| 10.5% | 11.9% | 8.4% | 6.9% | 11.1% | 3.9% | 8.2% | 4.5% | 7.1% | 7.9% | 7.5% | 13.1% | 50.2% | 9.2% | 40.9% | 1.7% | 1.7% | 1.4% | 3.5% | 5.0% | 5.0% | 7.3% | 3.3% | 4.2% | 3.1% | 21.1% | 93.1% | |
| – | 2.1% | 1.0% | 2.1% | 2.1% | 0.7% | 0.0% | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 85.0% | 81.1% | 84.8% | 86.1% | 82.3% | 62.2% | 84.1% | 83.1% | 79.0% | 70.7% | 62.6% | 58.0% | 34.7% | 56.9% | 56.9% | 32.4% | 96.8% | 95.5% | 70.6% | 68.3% | 67.0% | 61.2% | 65.2% | 50.9% | 42.9% | -46.4% | -137.0% | |
| -59.5% | -73.1% | -113.3% | -135.7% | -185.8% | -94.7% | -172.0% | -257.8% | -284.6% | -373.8% | -474.9% | -1,012.1% | -1,493.4% | -2,133.6% | -2,133.6% | -3,032.9% | -321.7% | -451.9% | -476.1% | -52.0% | -117.8% | -156.9% | -76.1% | -191.2% | -317.2% | -533.4% | -2,224.5% | |
| 0.0% | 0.0% | 0.7% | 0.0% | 0.0% | 1.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 8.0% | 11.4% | 11.4% | 0.7% | 0.1% | 0.3% | 0.3% | 0.4% | 0.6% | 0.7% | 0.4% | 0.7% | 1.3% | 2.2% | 18.1% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.